Maze Therapeutics, Inc. MAZE

26.05 (0.16) (0.61%) as of 25 Sep
Market cap
$1.5B
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Cash and Short Term Investments

+8 more quarters

383.94 341.92 352.38 411.09
Receivables
— — 20.00 —
Total current assets
391.30 349.72 379.78 420.42
Property, Plant, Equpment (Net)
5.54 5.04 4.68 4.39
Long-Term Investments
— 18.11 10.56 83.82
Long-term assets (Other)
4.30 4.14 5.41 4.55
Total non-current assets
30.76 47.41 39.93 111.20
Total Assets
422.06 397.13 419.71 531.63
Accounts Payable
2.92 1.79 4.01 2.21
Accrued Expenses
14.43 15.97 12.39 15.87
Total current liabilities
22.11 22.56 21.24 22.96
Long Term Debt (Total)
— — 38.83 38.96
Non-current Liabilities (Other)
1.09 1.09 0.39 —
Total non-current liabilities
20.51 19.61 56.77 55.54
Total liabilities
42.62 42.16 78.01 78.50
Additional Paid In Capital
834.30 844.35 855.54 1,011.99
Common Stock (Net)
0.05 0.05 0.05 0.06
Retained Earnings
(454.98) (489.55) (513.75) (558.48)
Common Equity (Total)
379.44 354.97 341.70 453.12
Shareholders Equity (Total)
379.44 354.97 341.70 453.12
Shareholders Equity and Liabilities (Total)
422.06 397.13 419.71 531.63
Shares (Common)
48.08 49.34 49.74 55.51
Shareholders Equity (Tangible)
379.44 354.97 341.70 453.12
Net Debt
(383.93) (341.92) (313.55) (372.13)
Total Debt
— — 38.83 38.96

Fold the line items

In millions of $ except per-share values · columns are period end dates